Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24304002 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B
Condition: Severe Hemophilia B
Interventions: Drug: Factor IX (rFIXFc);   Drug: rFIX

Indicates status has not been verified in more than two years